Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> ‘WHO As Fragile As It Is Indispensable’ – Report Probes Geneva Global Health Hub’s Response To COVID Crisis 12/03/2021 Geneva Solutions One year after the World Health Organization (WHO) declared the coronavirus outbreak a pandemic on 11 March 2020, a new report by the Foundation for Geneva has traced the success and the failures of the WHO and other international Geneva organisations in their response – as well as the implications for the future of multilateralism. […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> WHO & European Commission Announce Plan To Raise 7.5 Billion Euros To Ensure Equitable Access To COVID-19 Diagnostics, Drugs & Vaccines 24/04/2020 Grace Ren In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘WHO As Fragile As It Is Indispensable’ – Report Probes Geneva Global Health Hub’s Response To COVID Crisis 12/03/2021 Geneva Solutions One year after the World Health Organization (WHO) declared the coronavirus outbreak a pandemic on 11 March 2020, a new report by the Foundation for Geneva has traced the success and the failures of the WHO and other international Geneva organisations in their response – as well as the implications for the future of multilateralism. […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> WHO & European Commission Announce Plan To Raise 7.5 Billion Euros To Ensure Equitable Access To COVID-19 Diagnostics, Drugs & Vaccines 24/04/2020 Grace Ren In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> WHO & European Commission Announce Plan To Raise 7.5 Billion Euros To Ensure Equitable Access To COVID-19 Diagnostics, Drugs & Vaccines 24/04/2020 Grace Ren In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> WHO & European Commission Announce Plan To Raise 7.5 Billion Euros To Ensure Equitable Access To COVID-19 Diagnostics, Drugs & Vaccines 24/04/2020 Grace Ren In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> WHO & European Commission Announce Plan To Raise 7.5 Billion Euros To Ensure Equitable Access To COVID-19 Diagnostics, Drugs & Vaccines 24/04/2020 Grace Ren In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> WHO & European Commission Announce Plan To Raise 7.5 Billion Euros To Ensure Equitable Access To COVID-19 Diagnostics, Drugs & Vaccines 24/04/2020 Grace Ren In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> WHO & European Commission Announce Plan To Raise 7.5 Billion Euros To Ensure Equitable Access To COVID-19 Diagnostics, Drugs & Vaccines 24/04/2020 Grace Ren In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO & European Commission Announce Plan To Raise 7.5 Billion Euros To Ensure Equitable Access To COVID-19 Diagnostics, Drugs & Vaccines 24/04/2020 Grace Ren In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts